Quantcast
Home > Quotes > OSIR
OSIR

Osiris Therapeutics, Inc. Common Stock (OSIR) Quote & Summary Data

$10.4905
*  
0.0795
0.75%
Get OSIR Alerts
*Delayed - data as of Nov. 21, 2018 11:12 ET  -  Find a broker to begin trading OSIR now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    OSIR Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 10.40 / $ 10.59
Today's High / Low
$ 10.666 / $ 10.4905
Share Volume
701
50 Day Avg. Daily Volume
60,217
Previous Close
$ 10.57
52 Week High / Low
$ 13.70 / $ 7.30
Market Cap
362,193,807
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %

Intraday Chart

Shares Traded

Share Volume:
701
50 Day Avg. Daily Volume:
60,217

Trading Range

The current last sale of $10.4905 is 43.71% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 10.666 $ 13.70
 Low: $ 10.4905 $ 7.30

Company Description (as filed with the SEC)

Osiris Therapeutics, Inc., together with our wholly-owned subsidiary, Osiris Therapeutics International GmbH (collectively, "we," "us," "our," or the "Company"), researches, develops, manufactures and commercializes regenerative medicine products intended to improve the health and lives of patients and lower overall healthcare costs. We have achieved commercial success with products in orthopedics, sports medicine and wound care, including the Grafix product line, Stravix, BIO4 and Cartiform. We continue to advance our research and development ("R&D") by focusing on innovation in regenerative medicine, including the development of bioengineered stem cell and tissue-based products. We began operations in 1992 and were a Delaware corporation until, with the approval of our stockholders, we reincorporated as a Maryland corporation in May 2010.  ... More ...  

Nasdaq Official Price

Open Price:
$ 10.61
Open Date:
Nov. 21, 2018
Close Price:
N/A
Close Date:
N/A

Research Brokers before you trade

Want to trade FX?

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x